Stay updated on Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial
Sign up to get notified when there's something new on the Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial page.

Latest updates to the Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page footer revision has been updated from v3.5.2 to v3.5.3, reflecting a minor website version change without altering the displayed trial information.SummaryDifference0.1%

- Check24 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check45 days agoChange DetectedStandardized the disease name hyphenation to 'Alpha-1 antitrypsin deficiency'.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision: v3.5.0 is now displayed, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check89 days agoChange DetectedRevision: v3.4.2 is now shown, replacing v3.4.1, with no study content changes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial page.